Clinical trial
Feasibility Study to Compare OASIS Extracellular Matrix to Standard Wound Care for Treatment of Donor Site Wounds
NCT04079348 is registered in ClinicalTrials.gov with Cook Biotech Incorporated as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Feasibility Study to Compare OASIS Extracellular Matrix to Standard Wound Care for Treatment of Donor Site Wounds
- Lead sponsor
- Cook Biotech Incorporated
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- November 1, 2020
- Completion date
- December 31, 2025
- Enrollment
- 40 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
surgical wound, wound, wound heal, wounds and injuries